A Study to Evaluate the Efficacy of 18 to 24mg/Day Ropinirole Controlled Release (CR) Tablets in Early and Advanced Parkinson's Disease (PD) Patients.
Clinical trial NCT01929317 · TERMINATED
Trial details
- NCT number
- NCT01929317
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-28
- Primary completion
- 2014-09-16
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.